SCHEMBL19985059

SCHEMBL19985059

CN([SiH2]O[SiH2]O[SiH3])c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19984964 0.84 MEN1 (0.38) MEN1HTTKMT2A
SCHEMBL20130855 0.71 MEN1 (0.38) MEN1HTTKMT2A
Biphenyl SCHEMBL27732120 0.68 ALDH1A1 (0.47)
SCHEMBL16405945 0.68 MEN1 (0.42) MEN1HTTKMT2A
SCHEMBL19973291 0.67
SCHEMBL3133237 0.67 MEN1 (0.46) MEN1HTTKMT2A
Biphenyl SCHEMBL5194632 0.65 ALDH1A1 (0.39)
SCHEMBL8510220 0.65 MEN1 (0.44) MEN1HTTKMT2A
SCHEMBL2153932 0.64
SCHEMBL28147756 0.63 MEN1 (0.42) MEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10703915-B2 Compositions and methods for the deposition of silicon oxide films VERSUM MATERIALS US, LLC (US) 2020-07-07 US disclosed
US-20200040192-A9 Compositions and Methods for the Deposition of Silicon Oxide Films VERSUM MATERIALS US, LLC (US) 2020-02-06 US disclosed
US-20180127592-A1 Compositions and Methods for the Deposition of Silicon Oxide Films VERSUM MATERIALS US, LLC (US) 2018-05-10 US disclosed
US-20180127592-A1 Compositions and Methods for the Deposition of Silicon Oxide Films VERSUM MATERIALS US, LLC (US) 2018-05-10 US disclosed
WO-2018053129-A1 COMPOSITIONS AND METHODS FOR THE DEPOSITION OF SILICON OXIDE FILMS VERSUM MATERIALS US, LLC (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127592-A1 Compositions and Methods for the Deposition of Silicon Oxide Films SEPTIN9, SGMS1, SGMS2 MEN1 297/4885HTT 2490/4885KMT2A 1162/4885
US-20200040192-A9 Compositions and Methods for the Deposition of Silicon Oxide Films SEPTIN9, SGMS1, SGMS2 MEN1 297/4885HTT 2490/4885KMT2A 1162/4885
US-10703915-B2 Compositions and methods for the deposition of silicon oxide films SEPTIN9, SGMS1, SGMS2 MEN1 297/4885HTT 2490/4885KMT2A 1162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.